World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
74
Citations
19675
World Ranking
5599
National Ranking
158

Overview

Frederic Davi is affiliated with Assistance Publique - Hôpitaux de Paris in France. Their research primarily spans the field of Medicine, with substantial contributions to Genetics, Pathology and Forensic Medicine, and Immunology. They have also worked in Oncology and Radiology, Nuclear Medicine and Imaging.

The scientist's main research topics include:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Monoclonal and Polyclonal Antibodies Research
  • CNS Lymphoma Diagnosis and Treatment
  • T-cell and B-cell Immunology
  • Advanced Breast Cancer Therapies

Frederic Davi has published extensively in several key venues. Their frequent publication venues include:

  • Leukemia
  • Blood
  • HemaSphere
  • Haematologica
  • American Journal of Hematology

Some recent papers authored or co-authored by Frederic Davi are:

  • Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL, 2020, Blood
  • Molecular and clinical diversity in primary central nervous system lymphoma, 2022, Annals of Oncology
  • Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL, 2022, Leukemia
  • Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact, 2021, American Journal of Hematology
  • Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire, 2020, Blood Advances

The scientist collaborates frequently with several co-authors, including:

  • Κώστας Σταματόπουλος
  • Clotilde Bravetti
  • Anton W. Langerak
  • Paolo Ghia
  • Sylvain Choquet

Best Publications

  • Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

    J J M van Dongen;A W Langerak;M Brüggemann;P A S Evans

  • Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations

    Kostas Stamatopoulos;Chrysoula Belessi;Carol Moreno;Myriam Boudjograh

  • EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

    A. W. Langerak;P. J. T. A. Groenen;M. Brüggemann;K. Beldjord

  • Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

    V Leblond;F Davi;F Charlotte;R Dorent

  • Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

    Andreas Agathangelidis;Nikos Darzentas;Anastasia Hadzidimitriou;Xavier Brochet

  • Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis

    Fiona Murray;Nikos Darzentas;Anastasia Hadzidimitriou;Gerard Tobin

  • Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.

    V Leblond;L Sutton;R Dorent;F Davi

  • Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets: Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

    P. A. S. Evans;Ch Pott;P. J. T. A. Groenen;G. Salles

  • Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936.

    J H J M van Krieken;A W Langerak;E A Macintyre;M Kneba

  • ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia.

    Paolo Ghia;K. Stamatopoulos;C. Belessi;C. Moreno

  • Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene

    Paolo Ghia;Kostas Stamatopoulos;Chrysoula Belessi;Carol Moreno

  • Acquired initiating mutations in early hematopoietic cells of CLL patients

    Frederik Damm;Frederik Damm;Elena Mylonas;Elena Mylonas;Adrien Cosson;Adrien Cosson;Kenichi Yoshida

  • Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.

    M. Brüggemann;H. White;P. Gaulard;R. Garcia-Sanz

  • Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies.

    J Aubin;F Davi;F Nguyen-Salomon;D Leboeuf

  • Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative Disorders

    Véronique Leblond;Nathalie Dhedin;Marie-France Mamzer Bruneel;Sylvain Choquet

  • Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

    Monika Brüggemann;Michaela Kotrová;Henrik Knecht;Jack Bartram

  • Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

    Panagiotis Baliakas;Sabine Jeromin;Michalis Iskas;Anna Puiggros

  • The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.

    Pablo Oppezzo;Yuri Vasconcelos;Catherine Settegrana;Dominique Jeannel

  • Modulated expression of notch1 during thymocyte development

    RP Hasserjian;JC Aster;F Davi;DS Weinberg

  • Identification o f P rognostic F actors i n 6 1 P atients W ith Posttransplantat ion L ymphoproliferat ive D isorders

    Véronique Leblond;Nathalie Dhedin;Marie-France Mamzer Bruneel;Sylvain Choquet

Frequent Co-Authors

Richard Rosenquist
Richard Rosenquist Karolinska Institute
Paolo Ghia
Paolo Ghia Vita-Salute San Raffaele University
Kostas Stamatopoulos
Kostas Stamatopoulos Centre for Research and Technology Hellas
Šárka Pospíšilová
Šárka Pospíšilová Masaryk University
Véronique Leblond
Véronique Leblond Sorbonne University
David Oscier
David Oscier Royal Bournemouth Hospital
Anton W. Langerak
Anton W. Langerak Erasmus University Rotterdam
Nicholas Chiorazzi
Nicholas Chiorazzi Feinstein Institute for Medical Research
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Gunnar Juliusson
Gunnar Juliusson Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your education in Biology or Biochemistry can open doors to a variety of rewarding and flexible career paths, especially with the growing popularity of online learning. For those interested in the intersection of health, movement, and physiology, kinesiology online programs provide an excellent foundation for roles in sports medicine, rehabilitation, or human performance.

If you’re aiming to advance your nursing career, there are options for accelerated certifications. Programs like the shortest pmhnp certificate program and shortest online nurse practitioner program allow qualified nurses to specialize quickly in psychiatric mental health or family practice roles, filling vital gaps in healthcare.

Nutrition is another in-demand field closely tied to biology and biochemistry studies. A nutritionist degree online lets students gain vital knowledge in food science and health, with the affordability and flexibility that online programs offer.

No matter which path you choose, these diverse online degree options make it possible to build a career aligned with your interests and the latest developments in science and healthcare.

Best Scientists Citing Frederic Davi

Trending Scientists